Glen Eagle Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$389K Sell
8,398
-1,792
-18% -$83K 0.06% 181
2025
Q1
$622K Buy
10,190
+6,761
+197% +$412K 0.1% 130
2024
Q4
$194K Sell
3,429
-28
-0.8% -$1.58K 0.03% 241
2024
Q3
$179K Hold
3,457
0.03% 255
2024
Q2
$144K Sell
3,457
-539
-13% -$22.4K 0.03% 262
2024
Q1
$217K Sell
3,996
-52
-1% -$2.82K 0.04% 228
2023
Q4
$208K Sell
4,048
-13
-0.3% -$667 0.04% 226
2023
Q3
$236K Buy
4,061
+648
+19% +$37.6K 0.05% 206
2023
Q2
$218K Sell
3,413
-409
-11% -$26.1K 0.05% 220
2023
Q1
$265K Sell
3,822
-65
-2% -$4.51K 0.07% 197
2022
Q4
$280K Sell
3,887
-37
-0.9% -$2.66K 0.08% 182
2022
Q3
$279K Sell
3,924
-665
-14% -$47.3K 0.08% 175
2022
Q2
$353K Buy
4,589
+665
+17% +$51.2K 0.1% 161
2022
Q1
$287K Buy
3,924
+1,064
+37% +$77.7K 0.07% 192
2021
Q4
$178K Sell
2,860
-1,581
-36% -$98.6K 0.05% 223
2021
Q3
$263K Hold
4,441
0.08% 194
2021
Q2
$297K Buy
4,441
+101
+2% +$6.75K 0.09% 178
2021
Q1
$274K Buy
4,340
+286
+7% +$18.1K 0.1% 170
2020
Q4
$251K Sell
4,054
-26
-0.6% -$1.61K 0.1% 159
2020
Q3
$246K Buy
4,080
+81
+2% +$4.88K 0.11% 136
2020
Q2
$235K Buy
3,999
+121
+3% +$7.12K 0.12% 136
2020
Q1
$216K Buy
3,878
+170
+5% +$9.48K 0.15% 125
2019
Q4
$238K Buy
3,708
+601
+19% +$38.6K 0.13% 144
2019
Q3
$158K Buy
3,107
+80
+3% +$4.06K 0.1% 164
2019
Q2
$137K Sell
3,027
-864
-22% -$39.2K 0.09% 178
2019
Q1
$186K Sell
3,891
-45
-1% -$2.15K 0.14% 145
2018
Q4
$205K Buy
3,936
+1
+0% +$52 0.17% 126
2018
Q3
$244K Buy
3,935
+1
+0% +$62 0.17% 125
2018
Q2
$218K Sell
3,934
-61
-2% -$3.38K 0.17% 131
2018
Q1
$253K Sell
3,995
-150
-4% -$9.49K 0.21% 111
2017
Q4
$254K Buy
4,145
+234
+6% +$14.3K 0.22% 108
2017
Q3
$249K Buy
3,911
+749
+24% +$47.7K 0.23% 106
2017
Q2
$176K Sell
3,162
-53
-2% -$2.95K 0.14% 134
2017
Q1
$175K Sell
3,215
-544
-14% -$29.7K 0.15% 133
2016
Q4
$220K Buy
+3,759
New +$220K 0.2% 120